The Human Cytomegalovirus MHC Class I Homolog UL18 Inhibits LIR-1+ but Activates LIR-1− NK Cells1

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Immunology

• Publication date

  2007-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.178.7.4473PMID 17372005PMCID PMC2843079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytomegalovirus

  2016cited by this paper
• Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

  2006cited by this paper
• Regulation of NKG2D ligand gene expression.

  2006cited by this paper
• Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.

  2006cited by this paper
• Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus

  2005cited by this paper
• Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18.

  2005cited by this paper
• A high-efficiency system of natural killer cell cloning.

  2005cited by this paper
• Human Cytomegalovirus Encodes an MHC Class I-Like Molecule (UL142) That Functions to Inhibit NK Cell Lysis1

  2005cited by this paper
• Downregulation of natural killer cell–activating ligand CD155 by human cytomegalovirus UL141

  2005cited by this paper
• Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecules.

  2005cited by this paper
• Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis.

  2004cited by this paper
• Cutting Edge: CD96 (Tactile) Promotes NK Cell-Target Cell Adhesion by Interacting with the Poliovirus Receptor (CD155)

  2004cited by this paper
• Two Human ULBP/RAET1 Molecules with Transmembrane Regions Are Ligands for NKG2D1

  2004cited by this paper
• Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

  2004cited by this paper
• Genetic content of wild-type human cytomegalovirus.

  2004cited by this paper
• Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome.

  2004cited by this paper
• Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

  2003cited by this paper
• Effects of Human Cytomegalovirus Infection on Ligands for the Activating NKG2D Receptor of NK Cells: Up-Regulation of UL16-Binding Protein (ULBP)1 and ULBP2 Is Counteracted by the Viral UL16 Protein1

  2003cited by this paper
• Functional profiling of a human cytomegalovirus genome

  2003cited by this paper
• The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome.

  2003cited by this paper
• Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein

  2003cited by this paper
• LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients.

  2003cited by this paper
• Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G

  2003cited by this paper
• Recognition of a virus-encoded ligand by a natural killer cell activation receptor

  2002cited by this paper
• Identification and Expression of Human Cytomegalovirus Transcription Units Coding for Two Distinct Fcγ Receptor Homologs

  2002cited by this paper
• Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

  2002cited by this paper
• Human Cytomegalovirus (HCMV)‐Infected Endothelial Cells and Macrophages are Less Susceptible to Natural Killer Lysis Independent of the Downregulation of Classical HLA Class I Molecules or Expression of the HCMV Class I Homologue, UL18

  2002cited by this paper
• UL40-mediated NK evasion during productive infection with human cytomegalovirus

  2002cited by this paper
• Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors

  2002cited by this paper
• Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs.

  2002cited by this paper
• The MHC Class I Homolog of Human Cytomegalovirus Is Resistant to Down-Regulation Mediated by the Unique Short Region Protein (US)2, US3, US6, and US11 Gene Products1

  2002cited by this paper
• Human telomerase reverse transcriptase-immortalized MRC-5 and HCA2 human fibroblasts are fully permissive for human cytomegalovirus.

  2001cited by this paper
• ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

  2001cited by this paper
• Human Cytomegalovirus Open Reading Frame TRL11/IRL11 Encodes an Immunoglobulin G Fc-Binding Protein

  2001cited by this paper
• Down-regulation of MHC class I antigen presentation by HCMV; lessons for tumor immunology

  2000cited by this paper
• Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

  2000cited by this paper
• Human Cytomegalovirus Strain-Dependent Changes in NK Cell Recognition of Infected Fibroblasts1

  2000cited by this paper
• Functional characterization of HLA‐F and binding of HLA‐F tetramers to ILT2 and ILT4 receptors

  2000cited by this paper
• Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

  1999cited by this paper
• The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.

  1999cited by this paper
• The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones.

  1999cited by this paper
• Modulation of Natural Killer Cell Cytotoxicity in Human Cytomegalovirus Infection: The Role of Endogenous Class I Major Histocompatibility Complex and a Viral Class I Homolog

  1998cited by this paper
• A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules.

  1997cited by this paper
• A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells

  1997cited by this paper
• Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo

  1997cited by this paper
• The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells

  1997cited by this paper
• Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.

  1996influential reference
• Analysis of the complete DNA sequence of murine cytomegalovirus

  1996cited by this paper
• The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides.

  1995cited by this paper
• Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted

  1992cited by this paper
• A complex between the MHC class I homologue encoded by human cytomegalovirus and β2 microglobulin

  1990cited by this paper
• A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin.

  1990cited by this paper
• Severe herpesvirus infections in an adolescent without natural killer cells.

  1989cited by this paper
• Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens

  1988cited by this paper
• Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo

  1985cited by this paper

• Human Cytomegalovirus Immune Evasion of Natural Killer Cells: A Virus for All Seasons?

  2025influential citation
• Inhibitory leukocyte immunoglobulin-like receptors, subfamily B (LILRBs) in human diseases: structure, roles, mechanisms, and clinical applications

  2025cites this paper
• NK and T cell evasion mechanism of human cytomegalovirus

  2025cites this paper
• Downregulation of endogenous nectin1 in human keratinocytes by herpes simplex virus 1 glycoprotein D excludes superinfection but does not affect NK cell function

  2024cites this paper
• Human cytomegalovirus UL18 prevents priming of MHC-E– and MHC-II–restricted CD8+ T cells

  2024cites this paper
• Common Pathways Regulating Macrophage Differentiation and Breast Cancer Metastasis

  2024cites this paper
• Variable Surface Antigens of Plasmodium falciparum: Protein Families with Divergent Roles.

  2024cites this paper
• Oncolytic cytomegaloviruses expressing EGFR-retargeted fusogenic glycoprotein complex and drug-controllable interleukin 12

  2024cites this paper
• Evaluation of the In Vitro Capacity of Anti-Human Cytomegalovirus Antibodies to Initiate Antibody-Dependent Cell Cytotoxicity

  2024cites this paper
• Human leukocyte immunoglobulin-like receptors in health and disease

  2023cites this paper
• HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activation

  2023cites this paper
• Natural killer cells for antiviral therapy

  2023cites this paper
• The impact of HLA polymorphism on herpesvirus infection and disease

  2023cites this paper
• ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways

  2023cites this paper
• Insights into the Transcriptome of Human Cytomegalovirus: A Comprehensive Review

  2023cites this paper
• of HLA-I by the

  2023cites this paper
• ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways

  2023cites this paper
• Variants of HCMV UL18 Sequenced Directly from Clinical Specimens Associate with Antibody and T-Cell Responses to HCMV

  2022cites this paper
• Mechanisms for Host Immune Evasion Mediated by Plasmodium falciparum-Infected Erythrocyte Surface Antigens

  2022cites this paper
• Human inhibitory leukocyte Ig-like receptors: from immunotolerance to immunotherapy

  2022cites this paper
• Structural Models for Roseolovirus U20 And U21: Non-Classical MHC-I Like Proteins From HHV-6A, HHV-6B, and HHV-7

  2022cites this paper
• Elucidation of host-virus surfaceome interactions using spatial proteotyping.

  2021cites this paper
• mTOR Inhibitors Prevent CMV Infection through the Restoration of Functional αβ and γδ T cells in Kidney Transplantation

  2021cites this paper
• Virus-host protein interactions as footprints of human cytomegalovirus replication.

  2021cites this paper
• The New Kid on the Block: HLA-C, a Key Regulator of Natural Killer Cells in Viral Immunity

  2021cites this paper
• Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma.

  2021cites this paper
• Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus

  2021cites this paper
• Pathogenesis of human cytomegalovirus in the immunocompromised host

  2021cites this paper
• Playing chess with human cytomegalovirus

  2021cites this paper
• Macrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention

  2020cites this paper
• NK Cell Memory to Cytomegalovirus: Implications for Vaccine Development

  2020cites this paper
• Natural killer cells in multiple sclerosis: a review.

  2020cites this paper
• Tuning the Orchestra: HCMV vs. Innate Immunity

  2020cites this paper
• Mechanisms of Natural Killer Cell Evasion Through Viral Adaptation.

  2020cites this paper
• Downregulation of HLA-I by the molluscum contagiosum virus mc080 impacts NK-cell recognition and promotes CD8+ T-cell evasion

  2020cites this paper
• Les associations potentielles de gènes KIR avec la susceptibilité/résistance au développement de la maladie de Crohn

  2019cites this paper
• Modulation of innate and adaptive immunity by cytomegaloviruses

  2019cites this paper
• The Evolutionary Arms Race between Virus and NK Cells: Diversity Enables Population-Level Virus Control

  2019cites this paper
• Impact of TCR-ligand avidity for viral and tumor antigens on human CD8 T cell potency and long-term persistence

  2019cites this paper
• High-resolution analysis of human cytomegalovirus-specific T-cell receptor repertoires

  2019cites this paper
• On the Way to Become a Natural Killer Cell

  2019cites this paper
• Battle between Host Immune Cellular Responses and HCMV Immune Evasion

  2019cites this paper
• Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses

  2018cites this paper
• Regulation of cellular immunity by human cytomegalovirus

  2018cites this paper
• CMV and natural killer cells: shaping the response to vaccination

  2018cites this paper
• Herpesvirus Evasion of Natural Killer Cells

  2018cites this paper
• Analysis of MHC-I homologues in molluscum contagiosum and human cytomegalovirus

  2018cites this paper
• HLA-E Peptide Repertoire and Dimorphism—Centerpieces in the Adaptive NK Cell Puzzle?

  2018cites this paper
• Human Natural Killer Receptors, Co‐Receptors, and Their Ligands

  2018cites this paper
• Diversification of human NK cells: Lessons from deep profiling

  2018cites this paper
• An analysis of human cytomegalovirus gene family function

  2018cites this paper
• The Interplay between Natural Killer Cells and Human Herpesvirus-6

  2017cites this paper
• Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice

  2017cites this paper
• HIV patients, healthy aging and transplant recipients can reveal the hidden footprints of CMV.

  2017influential citation
• Human Cytomegalovirus Infection Increases Both Antibody- and Non–Antibody-Dependent Cellular Reactivity by Natural Killer Cells

  2017cites this paper
• Modulation of Human Leukocyte Antigen-C by Human Cytomegalovirus Stimulates KIR2DS1 Recognition by Natural Killer Cells

  2017cites this paper
• Leukocyte immunoglobulin‐like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies

  2017cites this paper
• Radboud Repository of the Radboud

  2017cites this paper
• Investigating and exploiting the latency-associated expression of the human cytomegalovirus gene US28 in early myeloid lineage cells.

  2017cites this paper
• Herpesviral capture of immunomodulatory host genes

  2017cites this paper
• Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy

  2017cites this paper
• Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation

  2017cites this paper
• Partial break in tolerance of NKG2A−/LIR-1− single KIR+ NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation

  2017cites this paper
• Natural Killer cell function after vaccination in an African (Gambian) population

  2017cites this paper
• Implications of genetic diversity on expression of LILRB1 in Natural Killer cells and susceptibility to HCMV infection in transplant patients

  2016cites this paper
• Identification of Targeting Factors Involved in the US2- and US11-Mediated Degradation of Major Histocompatibility Complex Class I Molecules

  2016cites this paper
• The effect of cytomegalovirus on natural killer cells and T cells in renal transplant recipients

  2016influential citation
• HCMV vCXCL1 Binds Several Chemokine Receptors and Preferentially Attracts Neutrophils over NK Cells by Interacting with CXCR2.

  2016cites this paper
• Viral Manipulation of Host Inhibitory Receptor Signaling for Immune Evasion

  2016cites this paper
• Asymptomatic CMV infections in long‐term renal transplant recipients are associated with the loss of FcRγ from LIR‐1+ NK cells

  2016cites this paper
• Leukocyte Immunoglobulin-Like Receptor 1-Expressing Human Natural Killer Cell Subsets Differentially Recognize Isolates of Human Cytomegalovirus through the Viral Major Histocompatibility Complex Class I Homolog UL18

  2016cites this paper
• Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies

  2016cites this paper
• Adaptive features of natural killer cells, lymphocytes of innate immunity

  2016cites this paper
• The Expanding Spectrum of Ligands for Leukocyte Ig-like Receptors

  2016cites this paper
• Human cytomegalovirus infection and the immune response to exercise.

  2016cites this paper
• Latent cytomegalovirus infection enhances anti‐tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans

  2016cites this paper
• CD57 in human natural killer cells and T-lymphocytes

  2016cites this paper
• Natural Killer Cell Diversity in Viral Infection: Why and How Much?

  2016cites this paper
• Towards understanding of Human Cytomegalovirus in Glioblastoma

  2016cites this paper
• Licensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral Control

  2016cites this paper
• Cytomegalovirus IgG in HIV+ persons on anti-retroviral therapy: characterisation and association with insulin resistance

  2016cites this paper
• Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations

  2015cites this paper
• Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells. Part II: impact of latent cytomegalovirus infection and catecholamine sensitivity.

  2015cites this paper
• A license to kill : The evolution of NK cell receptors

  2015cites this paper
• Leukocyte Ig-like Receptors The Expanding Spectrum of Ligands for

  2015cites this paper
• Analyse des propriétés antivirales des lymphocytes T Vgamma9Vdelta2 humains : potentiel immuno-thérapeutique au cours des infections par le cytomégalovirus humain

  2015cites this paper
• The evolution of natural killer cell receptors

  2015cites this paper
• Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle

  2015cites this paper
• NK cells and exercise: implications for cancer immunotherapy and survivorship.

  2015cites this paper
• Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages

  2015cites this paper
• Surveillance of cell and tissue perturbation by receptors in the LRC

  2015cites this paper
• Misdirected antibody responses against non-neutralizing epitopes on human Cytomegalovirus

  2014cites this paper
• The structure of cytomegalovirus immune modulator UL141 highlights structural Ig-fold versatility for receptor binding.

  2014cites this paper
• The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.

  2014cites this paper
• Know Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control

  2014cites this paper
• Human NK cell response to pathogens.

  2014cites this paper
• Etude des mécanismes régulateurs des cellules NK : rôle de la molécule PD-1 et de la prostaglandine E2 (PGE2)

  2014cites this paper
• Two Novel Human Cytomegalovirus NK Cell Evasion Functions Target MICA for Lysosomal Degradation

  2014cites this paper
• HCMV pUL135 Remodels the Actin Cytoskeleton to Impair Immune Recognition of Infected Cells

  2014cites this paper
• Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?

  2014cites this paper